Cambridge, 17 October 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is pleased to provide an update on Bleepa®.
The Company is considering a number of potential opportunities for Bleepa® following its launch at the NHS Expo in September 2019. The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa® pilot schemes in the near future.
To date, the Bleepa® product has been well received by the healthcare community and the Company believes that it will enable a number of healthcare providers to provide faster, safer, more efficient care. The Company looks forward to providing further updates in due course.
Tom Oakley, CEO of Feedback plc, said:
"We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives and clinicians at NHS Expo. The feedback that we have received is that Bleepa® clearly has applications across the healthcare sector, not only in individual hospital settings but also in community and cross site clinical settings. We look forward to making further announcements in relation to Bleepa®, in due course."
The Company continues to progress with its strategic review of TexRAD®, a longstanding part of the Feedback portfolio. The Company hopes to complete the strategic review by the end of the calendar year.
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.
Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa®, see www.bleepa.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
Feedback (LON:FDBK) specialises in medical imaging technology, such as magnetic resonance imaging (MRI) scans and X-Rays.
CEO Tom Oakley is a radiologist and understands the niche gaps in the medical imaging market and here he tells Proactive London how he's building a new revenue stream on the...